As
filed with the Securities and Exchange Commission on February 28, 2008.
Registration No. 333-_______
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
MAKO Surgical Corp.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
Delaware
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
20-1901148
(I.R.S. Employer
Identification No.)
|
2555 Davie Road
Ft. Lauderdale, Florida 33317
(Address, Including Zip Code, of Principal Executive Offices)
MAKO Surgical Corp. 2008 Omnibus Incentive Plan
(Full Title of the Plan)
MAKO Surgical Corp. 2008 Employee Stock Purchase Plan
(Full Title of the Plan)
MAKO Surgical Corp. 2004 Stock Incentive Plan
(Full Title of the Plan)
Maurice R. Ferré, M.D.
President, Chief Executive Officer and Chairman
MAKO Surgical Corp.
2555 Davie Road, Ft. Lauderdale, Florida 33317
(954) 927-2044
(Name, Address and Telephone Number, Including Area Code, of Agent for Service)
COPY TO:
Stuart A. Barr, Esq.
Hogan & Hartson LLP
555 Thirteenth Street, N.W.
Washington, D.C. 20004
Telephone: (202) 637-5600
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer
o
|
|
Accelerated filer
o
|
|
Non-accelerated
filer
x
|
|
Smaller reporting company
o
|
|
|
|
(Do not check if a smaller reporting company)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
Proposed
|
|
|
Proposed
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum
|
|
|
Maximum
|
|
|
|
|
|
Title Of
|
|
|
Amount
|
|
|
Offering
|
|
|
Aggregate
|
|
|
Amount Of
|
|
|
Securities
|
|
|
To Be
|
|
|
Price
|
|
|
Offering
|
|
|
Registration
|
|
|
To Be Registered
|
|
|
Registered(1)
|
|
|
Per Unit
|
|
|
Price
|
|
|
Fee
|
|
|
Common
Stock, par value $0.001 per share
|
|
|
871,483
|
(2)
|
|
|
$9.45(3)
|
|
|
$
|
8,235,514.35
|
|
|
|
$
|
323.66
|
|
|
|
Common Stock, par value $0.001 per share
|
|
|
213,220
|
(4)
|
|
|
$9.30(5)
|
|
|
$
|
1,982,946.00
|
|
|
|
$
|
77.93
|
|
|
|
Common
Stock, par value $0.001 per share
|
|
|
625,000
|
(6)
|
|
|
$9.45(3)
|
|
|
$
|
5,906,250.00
|
|
|
|
$
|
232.12
|
|
|
|
Common Stock, par value $0.001 per share
|
|
|
1,906,624
|
(7)
|
|
|
$4.81(8)
|
|
|
$
|
9,170,861.44
|
|
|
|
$
|
360.41
|
|
|
|
Total
|
|
|
3,616,327
|
|
|
|
|
|
|
$
|
25,295,571.79
|
|
|
|
$
|
994.12
|
|
|
|
|
|
|
(1)
|
|
This Registration Statement covers, in addition to the number of shares of
Common Stock stated above, options and other rights to purchase or acquire the
shares of Common Stock covered by the prospectus of the above-named plans and,
pursuant to Rule 416 under the Securities Act of 1933, as amended (the
Securities Act), any additional shares of Common Stock which become issuable
under the above-named plans by reason of any stock dividend, stock split,
recapitalization or other similar transaction effected without the receipt of
consideration which results in an increase in the number of outstanding shares of
Common Stock.
|
|
(2)
|
|
Represents 871,483 shares of Common Stock reserved for issuance under the
MAKO Surgical Corp. 2008 Omnibus Incentive Plan.
|
|
(3)
|
|
Pursuant to Rule 457(h), the maximum offering price, per share and in the
aggregate, and the registration fee were calculated based upon the average of the
high and low prices of the Common Stock on February 22, 2008, as reported on the
NASDAQ Global Market.
|
|
(4)
|
|
Represents 213,220 shares of Common Stock reserved for issuance upon
exercise of outstanding options granted under the MAKO Surgical Corp. 2008
Omnibus Incentive Plan.
|
|
(5)
|
|
Pursuant to Rule 457(h) and (c), calculated on the basis of the average of
the weighted average exercise price of outstanding options to purchase shares of
Common Stock under the MAKO Surgical Corp. 2008 Omnibus Incentive Plan.
|
|
(6)
|
|
Represents 625,000 shares of Common Stock reserved for issuance under the
MAKO Surgical Corp. 2008 Employee Stock Purchase Plan.
|
|
(7)
|
|
Represents 1,906,624 shares of Common Stock reserved for issuance upon exercise
of outstanding options granted under the MAKO Surgical Corp. 2004 Stock Incentive Plan.
No further option grants will be made under the 2004 Stock Incentive Plan.
|
|
(8)
|
|
Pursuant to Rule 457(h) and (c), calculated on the basis of the average of the
weighted average exercise price of outstanding options to purchase
shares of Common Stock
under the MAKO Surgical Corp. 2004 Stock Incentive Plan.
|
PART I
INFORMATION REQUIRED IN THE
SECTION 10(a) PROSPECTUS
The documents containing the information specified in Part I of Form S-8 (plan information and
Registrant information) have been or will be sent or given to
participants in the plans as specified
by Rule 428(b)(1) of the Securities Act of 1933, as amended (the Securities Act). Such documents
need not be filed with the Securities and Exchange Commission (the SEC) either as part of this
Registration Statement or as prospectuses or prospectus supplements pursuant to Securities Act Rule
424. These documents, which include the statement of availability required by Item 2 of Form S-8,
and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of
Form S-8 (Part II hereof), taken together, constitute a prospectus that meets the requirements of
Section 10(a) of the Securities Act.
2
PART II
INFORMATION REQUIRED IN THE
REGISTRATION STATEMENT
Item 3.
Incorporation of Documents by Reference
The following documents filed with the SEC by MAKO Surgical Corp. (the Company) are
incorporated herein by reference:
|
(a)
|
|
the final prospectus of the Company filed pursuant to Rule 424(b) under the
Securities Act in connection with the Registration Statement on Form S-1 (File No.
333-146162), filed with the SEC on February 14, 2008; and
|
|
|
(b)
|
|
the description of the common stock, par value $0.001 per share (the Common
Stock), of the Company contained in the Companys Registration Statement on Form 8-A,
filed on February 14, 2008 pursuant to Section 12 of the Securities Exchange Act of
1934, as amended (the Exchange Act), and all amendments or reports filed for the
purpose of updating such description.
|
All documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 or 15(d)
of the Exchange Act, prior to the filing of a post-effective amendment which indicates that all
securities offered hereby have been sold or which deregisters all securities then remaining unsold
shall be deemed to be incorporated by reference into this Registration Statement and to be a part
hereof from the date of filing of such documents. Any statement contained herein or in a document,
all or a portion of which is incorporated or deemed to be incorporated by reference herein, shall
be deemed to be modified or superseded for purposes of this Registration Statement to the extent
that a statement contained herein or in any other subsequently filed document which also is or is
deemed to be incorporated by reference herein modifies or supersedes such statement. Any such
statement so modified or superseded shall not be deemed, except as so modified or amended, to
constitute a part of this Registration Statement.
Item 4.
Description of Securities
Not applicable.
Item 5.
Interests of Named Experts and Counsel
Not applicable.
3
Item 6.
Indemnification of Directors and Officers
The Company is incorporated under the laws of the State of Delaware. Section 145 of the
Delaware General Corporation Law provides that a Delaware corporation may indemnify any persons who
are, or are threatened to be made, parties to any threatened, pending or completed action, suit or
proceeding, whether civil, criminal, administrative or investigative (other than an action by or in
the right of such corporation), by reason of the fact that such person was an officer, director,
employee or agent of such corporation, or is or was serving at the request of such person as an
officer, director, employee or agent of another corporation or enterprise. The indemnity may
include expenses (including attorneys fees), judgments, fines and amounts paid in settlement
actually and reasonably incurred by such person in connection with such action, suit or proceeding,
provided that such person acted in good faith and in a manner he or she reasonably believed to be
in or not opposed to the corporations best interests and, with respect to any criminal action or
proceeding, had no reasonable cause to believe that his or her conduct was illegal. A Delaware
corporation may indemnify any persons who are, or are threatened to be made, a party to any
threatened, pending or completed action or suit by or in the right of the corporation by reason of
the fact that such person was a director, officer, employee or agent of such corporation, or is or
was serving at the request of such corporation as a director, officer, employee or agent of another
corporation or enterprise. The indemnity may include expenses (including attorneys fees) actually
and reasonably incurred by such person in connection with the defense or settlement of such action
or suit provided such person acted in good faith and in a manner he or she reasonably believed to
be in or not opposed to the corporations best interests except that no indemnification is
permitted without judicial approval if the officer or director is adjudged to be liable to the
corporation. Expenses incurred by any officer or director in defending any such action, suit or
proceeding in advance of its final disposition shall be paid by the Company upon delivery to the
Company of an undertaking, by or on behalf of such director or officer, to repay all amounts so
advanced if it shall ultimately be determined that such director or officer is not entitled to be
indemnified by the Company. Where an officer or director is successful on the merits or otherwise
in the defense of any action referred to above, the corporation must indemnify him or her against
the expenses which such officer or director has actually and reasonably incurred. The Companys
third amended and restated certificate of incorporation and third amended and restated bylaws
provide for the indemnification of the Companys directors and officers to the fullest extent
permitted under the Delaware General Corporation Law.
Section 102(b)(7) of the Delaware General Corporation Law permits a corporation to provide in
its certificate of incorporation that a director of the corporation shall not be personally liable
to the corporation or its stockholders for monetary damages for breach of fiduciary duties as a
director, except for liability for any:
|
|
|
transaction from which the director derives an improper personal benefit,
|
|
|
|
|
act or omission not in good faith or that involves intentional misconduct or
a knowing violation of law,
|
|
|
|
|
unlawful payment of dividends or redemption of shares, or
|
4
|
|
|
breach of a directors duty of loyalty to the corporation or its stockholders.
|
The Companys third amended and restated certificate of incorporation includes such a provision.
Section 174 of the Delaware General Corporation Law provides, among other things, that a
director, who willfully or negligently approves of an unlawful payment of dividends or an unlawful
stock purchase or redemption, may be held liable for such actions. A director who was either absent
when the unlawful actions were approved, or dissented at the time, may avoid liability by causing
his or her dissent to such actions to be entered in the books containing minutes of the meetings of
the board of directors at the time such action occurred or immediately after such absent director
receives notice of the unlawful acts.
As
permitted by the Delaware General Corporation Law, the Company
intends to enter into indemnity
agreements with each of its directors and executive officers, that require the Company to indemnify
such persons against any and all expenses (including attorneys fees), witness fees, damages,
judgments, fines, settlements and other amounts incurred (including expenses of a derivative
action) in connection with any action, suit or proceeding, whether actual or threatened, to which
any such person may be made a party by reason of the fact that such person is or was a director, an
officer or an employee of the Company or any of its affiliated enterprises, provided that such
person acted in good faith and in a manner such person reasonably believed to be in or not opposed
to the Companys best interests and, with respect to any criminal proceeding, had no reasonable
cause to believe his or her conduct was unlawful. The indemnity agreements also set forth
certain procedures that will apply in the event of a claim for indemnification thereunder.
At present, there is no pending litigation or proceeding involving any of the Companys
directors or executive officers as to which indemnification is required or permitted, and the
Company is not aware of any threatened litigation or proceeding that may result in a claim for
indemnification.
The Company has an insurance policy covering its officers and directors with respect to
certain liabilities, including liabilities arising under the Securities Act or otherwise.
5
Item 7.
Exemption from Registration Claimed
Not applicable.
Item 8.
Exhibits
See the attached Exhibit Index.
Item 9.
Undertakings
The undersigned Registrant hereby undertakes:
|
(1)
|
|
To file, during any period in which offers or sales are being
made, a post-effective amendment to this registration statement:
|
|
(a)
|
|
To include any prospectus required by Section
10(a)(3) of the Securities Act of 1933;
|
|
|
(b)
|
|
To reflect in the prospectus any facts or
events arising after the effective date of the registration statement
(or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the
information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered
(if the total dollar value of securities offered would not exceed that
which was registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of
prospectus filed with the SEC pursuant to Rule 424(b) if, in the
aggregate, the changes in volume and price represent no more than 20
percent change in the maximum aggregate offering price set forth in the
Calculation of Registration Fee table in the effective registration
statement.
|
|
|
(c)
|
|
To include any material information with
respect to the plan of distribution not previously disclosed in the
registration statement or any material change to such information in
the registration statement;
|
|
|
|
provided
,
however
, that paragraphs (1)(a) and (1)(b) do not apply if
the information required to be included in a post-effective amendment by those
paragraphs is contained in periodic reports filed by the Registrant pursuant to
Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are
incorporated by reference in the registration statement.
|
|
|
(2)
|
|
That, for the purpose of determining any liability under the Securities Act,
each such post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that
time shall be deemed to be the initial bona fide offering thereof.
|
|
|
(3)
|
|
To remove from registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination of the offering.
|
6
|
(4)
|
|
The undersigned Registrant hereby undertakes that, for purposes of determining
any liability under the Securities Act, each filing of the Registrants annual report
pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable,
each filing of an employee benefit plans annual report pursuant to Section 15(d) of
the Exchange Act) that is incorporated by reference in the registration statement shall
be deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be the
initial bona fide offering thereof.
|
|
|
(5)
|
|
Insofar as indemnification for liabilities arising under the Securities Act of
1933 may be permitted to directors, officers and controlling persons of the Registrant
pursuant to the foregoing provisions, or otherwise, the Registrant has been advised
that in the opinion of the Securities and Exchange Commission such indemnification is
against public policy as expressed in the Act and is, therefore, unenforceable. In the
event that a claim for indemnification against such liabilities (other than the payment
by the Registrant of expenses incurred or paid by a director, officer or controlling
person of the Registrant in the successful defense of any action, suit or proceeding)
is asserted by such director, officer or controlling person in connection with the
securities being registered, the Registrant will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public policy
as expressed in the Act and will be governed by the final adjudication of such issue.
|
7
SIGNATURES
Pursuant to the requirements of the Securities Act, the Registrant certifies that it has
reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Ft. Lauderdale, State of Florida, on
February 28, 2008.
|
|
|
|
|
|
MAKO SURGICAL CORP
.
|
|
|
By:
|
/s/
Maurice R. Ferré
|
|
|
|
Maurice R. Ferré
|
|
|
|
President, Chief Executive Officer and Chairman
(Principal
Executive Officer)
|
|
|
8
POWER OF ATTORNEY
Each person whose signature appears below constitutes and appoints Maurice R. Ferré and Fritz
L. LaPorte, and each of them individually, his true and lawful attorney-in-fact and agent, with
full powers of substitution and resubstitution, for him and in his name, place and stead, in any
and all capacities, to sign any and all amendments (including post-effective amendments) to this
Registration Statement, and to file the same, with all exhibits thereto, and other documents in
connection therewith, with the SEC, granting unto said attorneys-in-fact and agents, and each of
them individually, full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the premises, as fully to all intents and purposes
as he or she might or could do in person, hereby ratifying and confirming all that said
attorneys-in-fact and agents, or any of them individually, or their substitute or substitutes, may
lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act, this Registration Statement has been
signed below by the following persons in the capacities and on the dates indicated.
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
/s/ Maurice R. Ferré
Maurice R. Ferré
|
|
President, Chief
Executive Officer and
Chairman (Principal
Executive Officer)
|
|
February 28, 2008
|
/s/ Fritz L. LaPorte
Fritz L. LaPorte
|
|
Senior Vice President
of Finance and
Administration, Chief
Financial Officer and
Treasurer (Principal
Financial Officer and
Principal Accounting
Officer)
|
|
February 28, 2008
|
/s/ S. Morry Blumenfeld
S. Morry Blumenfeld
|
|
Director
|
|
February 28, 2008
|
/s/ Gerald A. Brunk
Gerald A. Brunk
|
|
Director
|
|
February 28, 2008
|
/s/ Marcelo G. Chao
Marcelo G. Chao
|
|
Director
|
|
February 28, 2008
|
/s/ Christopher C. Dewey
Christopher C. Dewey
|
|
Director
|
|
February 28, 2008
|
/s/ Charles W. Federico
Charles W. Federico
|
|
Director
|
|
February 28, 2008
|
/s/ Frederic H. Moll
Frederic H. Moll
|
|
Director
|
|
February 28, 2008
|
/s/ Michael P. Stansky
Michael P. Stansky
|
|
Director
|
|
February 28, 2008
|
9
EXHIBIT INDEX
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
5.1
|
|
Opinion of Hogan & Hartson L.L.P.
|
|
|
|
23.1
|
|
Consent of Ernst & Young LLP
|
|
|
|
23.2
|
|
Consent of Hogan & Hartson L.L.P. (included in Exhibit 5.1)
|
|
|
|
24.1
|
|
Power of Attorney (included in this Registration Statement under Signatures)
|
|
|
|
99.1
|
|
MAKO Surgical Corp. 2008 Omnibus Incentive Plan (incorporated herein by reference to Exhibit
10.3 of Amendment No. 4 to the Registration Statement on Form S-1/A filed by MAKO Surgical
Corp., File No. 333-146162, on January 31, 2008)
|
|
|
|
99.2
|
|
MAKO Surgical Corp. 2008 Employee Stock Purchase Plan (incorporated herein by reference to
Exhibit 10.4 of Amendment No. 4 to the Registration Statement on Form S-1/A filed by MAKO
Surgical Corp., File No. 333-146162, on January 31, 2008)
|
|
|
|
99.3
|
|
MAKO Surgical Corp. 2004 Stock Incentive Plan (incorporated herein by reference to Exhibit
10.2 of Amendment No. 4 to the Registration Statement on Form S-1/A filed by MAKO Surgical
Corp., File No. 333-146162, on January 31, 2008)
|
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jul 2023 to Jul 2024